About
Technology
Issues
FAQ
Search
filter by year
2024 (2,314)
2023 (36,196)
2022 (102,536)
2021 (114,397)
2020 (101,044)
2010-2019 (562,623)
2000-2009 (217,158)
1990-1999 (105,344)
1980-1989 (54,136)
1970-1979 (26,731)
1960-1969 (12,788)
1950-1959 (5,919)
1900-1950 (7,991)
Similar Keywords
factors (1,195,934)
that (209,273)
1-20 of (1,402,726 documents found)
2013
6
Epigenetics as the Underlying Mechanism for Monozygotic Twin Discordance
Medical Epigenetics
(
262.3
★★★
), 1, 3-18.
Cite
Citations
Matthew Li (80, 6.9K)
2019
157
The current state of molecular testing in the treatment of patients with solid tumors, 2019
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 69, 305-343.
Cite
Citations
Matthew Li (80, 6.9K)
2015
219
A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 65, 221-238.
Cite
Citations
Matthew Li (80, 6.9K)
2020
98
Enhancing global access to cancer medicines
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 70, 105-124.
Cite
Citations
Matthew Li (80, 6.9K)
2010
192
Cancer, Culture, and Health Disparities: Time to Chart a New Course?
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 60, 12-39.
Cite
Citations
Matthew Li (80, 6.9K)
2022
52
American Cancer Society's report on the status of cancer disparities in the United States, 2021
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 72, 112-143.
Cite
Citations
Matthew Li (80, 6.9K)
2007
136
Cancer Risk Elicitation and Communication: Lessons from the Psychology of Risk Perception
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 57, 147-167.
Cite
Citations
Matthew Li (80, 6.9K)
2018
39
Factors influencing risk‐based care of the childhood cancer survivor in the 21st century
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 68, 133-152.
Cite
Citations
Matthew Li (80, 6.9K)
2018
35
Update on infection control practices in cancer hospitals
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 68, 340-355.
Cite
Citations
Matthew Li (80, 6.9K)
2022
22
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 72, 34-56.
Cite
Citations
Matthew Li (80, 6.9K)
2009
81
Screening for Prostate Cancer
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 59, 264-273.
Cite
Citations
Matthew Li (80, 6.9K)
2012
43
Cancer‐related risk factors and preventive measures in US Hispanics/Latinos
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 62, 353-363.
Cite
Citations
Matthew Li (80, 6.9K)
2013
28
Risk factors, pathophysiology, and treatment of hot flashes in cancer
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 63, 167-192.
Cite
Citations
Matthew Li (80, 6.9K)
2012
26
Challenges in ductal carcinoma in situ risk communication and decision‐making
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 62, 203-210.
Cite
Citations
Matthew Li (80, 6.9K)
2018
1.4K
Environment dominates over host genetics in shaping human gut microbiota
Nature
(
13.7
★★★
), 555, 210-215.
Cite
Citations
Matthew Li (80, 6.9K)
2014
1.1K
The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing
Nature Reviews Immunology
(
10.6
★★★
), 14, 585-600.
Cite
Citations
Matthew Li (80, 6.9K)
2020
316
The role of chemical design in the performance of organic semiconductors
Nature Reviews Chemistry
(
13.8
★★★
), 4, 66-77.
Cite
Citations
Matthew Li (80, 6.9K)
2019
1.9K
Progress and Perspectives of Electrochemical CO
2
Reduction on Copper in Aqueous Electrolyte
Chemical Reviews
(
23.0
★★★
), 119, 7610-7672.
Cite
Citations
Matthew Li (80, 6.9K)
2009
8.5K
Heterogeneous photocatalyst materials for water splitting
Chemical Society Reviews
(
18.7
★★★
), 38, 253-278.
Cite
Citations
Matthew Li (80, 6.9K)
2006
19.7K
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
Cell
(
13.5
★★★
), 126, 663-676.
Cite
Citations
Matthew Li (80, 6.9K)
1
2
3
site/software ©
exaly
; All materials licenced under
CC by-SA
.
